War on cancer: Duke spinout pursues revolutionary treatment using polio vaccine - WRAL Tech Wire
War on cancer: Duke spinout pursues revolutionary treatment using polio vaccine - WRAL Tech Wire War on cancer: Duke spinout pursues revolutionary treatment using polio vaccine - WRAL Tech Wire Posted: 10 Dec 2020 12:00 AM PST DURHAM – A Duke University spinout has developed an immune-boosting technology using variations of the polio vaccine that does more than wipe out a targeted solid tumor. "It clears the body of others as well, not just where it's injected," said Matt Stober, president and CEO of RTP-based Istari Oncology . Istari's primary technology platform is the Polio Virus Sabin-Rhinovirus Poliovirus (PVSRIPO). The results from multiple trials and preclinical research streams indicate that PVSRIPO has the potential to treat a variety of solid tumors that were previously thought of as untreatable. Although the company began by focusing on the deadly brain cancer glioblastoma multiform, a treatment in Phase I...